D
Dan Lindholm
Researcher at Minerva Foundation Institute for Medical Research
Publications - 266
Citations - 25963
Dan Lindholm is an academic researcher from Minerva Foundation Institute for Medical Research. The author has contributed to research in topics: Nerve growth factor & Neurotrophic factors. The author has an hindex of 70, co-authored 235 publications receiving 23924 citations. Previous affiliations of Dan Lindholm include University of Melbourne & Max Planck Society.
Papers
More filters
Journal ArticleDOI
Tri-iodothyronine regulates survival and differentiation of rat cerebellar granule neurons.
TL;DR: Antibodies against microtubule associated protein Tau, which is expressed in developing neurites, showed that T3 also enhanced neurite formation.
Journal ArticleDOI
Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome.
TL;DR: The normal serum levels of nerve growth factor and brain-derived neurotrophic factor together and previously reported low levels of the factor in cerebrospinal fluid indicate that the latter may reflect low levels in the central nervous system.
Journal ArticleDOI
Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction.
Jonathan W. Cunningham,Muthiah Vaduganathan,Brian Claggett,Ian J. Kulac,Akshay S. Desai,Pardeep S. Jhund,W. De Boer,David L. DeMets,Adrian F. Hernandez,Silvio E. Inzucchi,Mikhail Kosiborod,Carolyn S.P. Lam,Felipe Martinez,Martina M. McGrath,Eileen O'Meara,Ulrica Wilderäng,Dan Lindholm,Magnus Petersson,Anna Maria Langkilde,John J.V. McMurray,Scott D. Solomon +20 more
TL;DR: The DELIVER trial as mentioned in this paper randomized patients with mild reduced or preserved left ventricular ejection fraction (LVEF) who were enrolled during or following hospitalization to dapagliflozin.
Journal ArticleDOI
c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson's Disease.
Dan Lindholm,Dan Lindholm,Dan D. Pham,Dan D. Pham,Annunziata Cascone,Ove Eriksson,Krister Wennerberg,Mart Saarma +7 more
TL;DR: More rigorously controlled and well-designed trials are needed before the c-Abl inhibitors can be used in the neuroclinic to possibly benefit an increasing number of PD patients.
Journal ArticleDOI
Involvement of estrogen receptors in the resveratrol-mediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female mice.
Valentina Di Liberto,Johanna Mäkelä,Laura Korhonen,Melania Olivieri,Timofey V. Tselykh,Annika Mälkiä,Hai Do Thi,Natale Belluardo,Dan Lindholm,Giuseppa Mudò +9 more
TL;DR: Results show that estrogen receptors are involved in the up-regulation of DAT by RSV in the dopaminergic neurons, demonstrating a sex-dependent effect of RSVIn the brain that may be of clinical importance.